ARTICLE | Clinical News
Masitinib: Phase II ongoing
March 9, 2015 7:00 AM UTC
AB Science said an independent DSMB recommended continuation of a Phase II trial evaluating oral masitinib in combination with gemcitabine, carboplatin or capecitabine in patients based on a review of...